ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(1,1-dimethylethoxy)carbonyl]-D-ornithine
C24H38N4O7S
526.6 g/mol
Pharmaceutical Intermediate

N5-((((2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl)amino)iminomethyl)-N2-((1,1-dimethylethoxy)carbonyl)-D-ornithine

CAS186698-61-3
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a protected form of the amino acid D-arginine, featuring a Boc (tert-butyloxycarbonyl) group on the amine and a Pbf (2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-sulfonyl) group on the guanidino side chain. It is primarily used as a building block in solid-phase peptide synthesis.

Building block for peptide synthesisResearch reagent for pharmaceutical intermediate production

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ApplicationSame Use

Fmoc-L-Glutamic acid-O-tert-butyl ester hydrate

CAS204251-24-1

pharmaceutical intermediate

ApplicationSame Use

N-Benzyloxycarbonyl-L-asparagine

CAS2304-96-3

pharmaceutical intermediate

ApplicationSame Use

N-Boc-N'-Cbz-L-lysine

CAS2389-45-9

pharmaceutical intermediate

ApplicationSame Use

N-Boc-L-Lysine

CAS13734-28-6

pharmaceutical intermediate

ReferenceSame Category

2,6-Dichloroquinoxaline

CAS18671-97-1

pharmaceutical intermediate

ReferenceSame Category

(3beta)-16-[(3beta)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate

CAS186826-68-6

pharmaceutical intermediate

ReferenceSame Category

Ambroxol EP Impurity B

CAS18683-95-9

pharmaceutical intermediate

ReferenceSame Category

Carbamic acid, N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl ester

CAS1869118-24-0

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2R)-5-[[amino-[(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-yl)sulfonylamino]methylidene]amino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid

InChIKey

CVFXPOKENLGCID-QGZVFWFLSA-N

SMILES

CC1=C(C(=C(C2=C1OC(C2)(C)C)C)S(=O)(=O)NC(=NCCC[C@H](C(=O)O)NC(=O)OC(C)(C)C)N)C

Synonyms (10)
  • Boc-D-Arg(Pbf)-OH

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→